Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Express Scripts gives AbbVie exclusive Hepatitis C billing
CNBC
Mon, 12/22/14 - 09:27 am
Tags:
Express Scripts, AbbVie, hepatitis C, Viekira Pak
FDA approves AbbVie’s hepatitis treatment
Marketwatch
Fri, 12/19/14 - 03:58 pm
Tags:
FDA, AbbVie, hepatitis C, Viekira Pak
The top 10 patent losses of 2015
Fierce Pharma
Fri, 12/19/14 - 08:35 am
Tags:
patents, Lantus, Abilify, Copaxone, Neulasta, Tracleer, Namenda, Avodart, Jalyn, Zyvox, Androgel, Synagis, Sanofi, Bristol-Myers Squibb, Otsuka, Teva Pharmaceutical, Amgen, Actelion, Actavis, GSK, Pfizer, AbbVie, AstraZeneca
AbbVie: Here’s How It Could Differentiate Itself From Gilead
Barron's
Thu, 12/18/14 - 04:04 pm
Tags:
AbbVie, Gilead Sciences, hepatitis C, drug pricing
Banks lost big betting on canceled AbbVie-Shire merger
Fierce Pharma
Mon, 12/15/14 - 06:58 pm
Tags:
AbbVie, Shire, M&A
Could the World's Top-Selling Drug Be Toppled?
Motley Fool
Mon, 12/15/14 - 09:03 am
Tags:
AbbVie, Humira, Cadila, biosimilars, Sovaldi, Harvoni, Gilead Sciences
These 2 Biotech Stocks Are Set To Split The $15 Billion Hepatitis C Market
Yahoo/Benzinga
Sat, 12/13/14 - 11:29 am
Tags:
Gilead Sciences, AbbVie, hepatitis, hepatitis C
These 2 Biotech Stocks Are Set To Split The $15 Billion Hepatitis C Market
Yahoo/Benzinga
Fri, 12/12/14 - 07:17 pm
Tags:
hepatitis C, Gilead Sciences, Sovaldi, Harvoni, AbbVie
Why Gilead Sciences and AbbVie Care About This Tiny Company
Motley Fool
Thu, 12/11/14 - 10:32 am
Tags:
AbbVie, Gilead Sciences, Achillion, hepatitis C
Gilead Sciences: Still Waiting on AbbVie
Barron's
Tue, 12/9/14 - 04:03 pm
Tags:
Gilead Sciences, AbbVie, hepatitis C
India's Cadila launches first cheaper copy of world's top-selling drug
Yahoo/Reuters
Tue, 12/9/14 - 07:51 am
Tags:
India, Cadila, AbbVie, Humira, biosimilars
AbbVie oncology pipeline continues to show progress
Medical Marketing and Media
Mon, 12/8/14 - 11:21 pm
Tags:
AbbVie, oncology
Sovaldi Versus Abbvie Combination: Analysis Of Abbvie Combination Impact On Sovaldi Market Share
Seeking Alpha
Tue, 12/2/14 - 08:54 am
Tags:
Sovaldi, AbbVie, Gilead Sciences, hepatitis C
AbbVie adds children's AIDS drugs to shared patent pool
Yahoo/Reuters
Mon, 12/1/14 - 07:56 am
Tags:
AbbVie, AIDS, patents
AbbVie Acquires Manufacturing Facility in Singapore; Further Expands Capabilities in Asia
Yahoo
Fri, 11/21/14 - 08:12 am
Tags:
AbbVie, Singapore, drug manufacturing, Asia
Europe gives green light to AbbVie hepatitis C medicine, others
Yahoo/Reuters
Fri, 11/21/14 - 08:11 am
Tags:
Europe, AbbVie, hepatitis C, dasabuvir, Sanofi, eliglustat, Novartis, secukinumab, Merck, Vorapaxar, Boehringer Ingelheim, nintedanib
Why are M&A hedge funds gun shy? Blame AbbVie for killing its Shire deal
Fierce Pharma
Fri, 11/14/14 - 09:53 am
Tags:
M&A, AbbVie, Shire
4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic
24/7 Wall St
Thu, 11/13/14 - 09:34 am
Tags:
hepatitis C, AbbVie, Achillion, Gilead Sciences, Merck
Are Expensive Biotech Drugs Bad For Business?
Seeking Alpha
Tue, 11/11/14 - 10:53 am
Tags:
drug pricing, biotech, AbbVie, AstraZeneca, Bristol-Myers Squibb, Dendreon, Gilead Sciences, GSK, Merck, Novartis, Teva Pharmaceutical, Vertex Pharmaceuticals
AbbVie Hepatitis C Drug Cures 97% in Transplant Patients Study
Bloomberg
Tue, 11/11/14 - 09:55 am
Tags:
AbbVie, hepatitis C, ombitasvir, ritonavir, dasabuvir, ABT-450

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.